West Pharmaceutical Services, Inc. Stock BOERSE MUENCHEN
Stocks
WPS
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 307.55 EUR | +0.87% |
|
+6.65% | +31.54% |
| Market Cap | 24.79B 21.73B 20.03B 18.75B 35.17B 2,338B 35.9B 241B 93.17B 1,156B 93.07B 91.04B 4,007B | P/E 2026 * |
41.7x | P/E 2027 * | 36.5x |
|---|---|---|---|---|---|
| Enterprise Value | 24.05B 21.08B 19.43B 18.19B 34.12B 2,268B 34.82B 234B 90.38B 1,121B 90.29B 88.32B 3,887B | EV / Sales 2026 * |
7.22x | EV / Sales 2027 * | 6.72x |
| Free-Float |
93.54% | Yield 2026 * |
0.26% | Yield 2027 * | 0.28% |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 week | +8.25% | ||
| Current month | +11.03% | ||
| 1 month | +12.99% | ||
| 3 months | +42.65% | ||
| 6 months | +31.38% | ||
| Current year | +32.68% |
| 1 week | 284.1 |  | 308.15 |
| 1 month | 265.2 | | 308.15 |
| 3 years | 168.65 | | 386.1 |
| 5 years | 168.65 | | 418.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 2015-04-23 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.87% | +6.65% | +63.63% | -8.41% | 24.48B | |
| +0.94% | +6.46% | -31.50% | -12.89% | 162B | |
| +1.48% | +2.07% | -5.80% | -7.43% | 103B | |
| -0.29% | +5.26% | -2.12% | +52.46% | 55.83B | |
| -2.09% | -10.31% | +49.00% | +52.19% | 54.05B | |
| +3.00% | +8.29% | -8.77% | -39.22% | 41.71B | |
| +2.91% | +8.15% | - | - | 31.94B | |
| +2.17% | -3.22% | -17.17% | -44.66% | 26.49B | |
| +2.41% | +6.45% | -10.28% | +2.31% | 20.52B | |
| +0.84% | -2.08% | -17.51% | -3.19% | 20.02B | |
| Average | +0.79% | +0.80% | +2.17% | -0.98% | 57.34B | |
| Weighted average by Cap. | +0.47% | +1.93% | -5.91% | -0.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.33B 2.92B 2.69B 2.52B 4.73B 314B 4.82B 32.36B 12.52B 155B 12.51B 12.24B 539B | 3.54B 3.1B 2.86B 2.68B 5.02B 334B 5.12B 34.36B 13.3B 165B 13.28B 12.99B 572B |
| Net income | 605M 530M 489M 458M 858M 57.04B 876M 5.87B 2.27B 28.19B 2.27B 2.22B 97.75B | 686M 601M 554M 519M 973M 64.67B 993M 6.66B 2.58B 31.96B 2.57B 2.52B 111B |
| Net Debt | -741M -650M -599M -561M -1.05B -69.94B -1.07B -7.2B -2.79B -34.57B -2.78B -2.72B -120B | -1.03B -900M -830M -777M -1.46B -96.82B -1.49B -9.97B -3.86B -47.85B -3.85B -3.77B -166B |
| Date | Price | Change |
|---|---|---|
| 26-06-26 | €307.55 | +0.87% |
| 26-06-25 | €304.90 | +1.50% |
| 26-06-24 | €300.40 | +1.76% |
| 26-06-23 | €295.20 | +2.55% |
| 26-06-22 | €287.85 | +1.32% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
- WPS Stock
Select your edition
All financial news and data tailored to specific country editions
